Guardion Health Sciences (Guardion Health Sciences) Price-to-Operating-Cash-Flow : (As of Jun. 01, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Guardion Health Sciences Price-to-Operating-Cash-Flow?

As of today (2024-06-01), Guardion Health Sciences's share price is $9.53. Guardion Health Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.56. Hence, Guardion Health Sciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Guardion Health Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

GHSI's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.13
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Guardion Health Sciences's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-0.59. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.56.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 50.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 43.90% per year.

During the past 9 years, Guardion Health Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.40% per year. The lowest was -53.40% per year. And the median was 20.95% per year.

Guardion Health Sciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Guardion Health Sciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardion Health Sciences Price-to-Operating-Cash-Flow Chart

Guardion Health Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Guardion Health Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Guardion Health Sciences's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Guardion Health Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guardion Health Sciences's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guardion Health Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Guardion Health Sciences's Price-to-Operating-Cash-Flow falls into.

Guardion Health Sciences Price-to-Operating-Cash-Flow Calculation

Guardion Health Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9.53	/	-2.557
	=

Guardion Health Sciences's Share Price of today is $9.53.
Guardion Health Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.56.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Guardion Health Sciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Guardion Health Sciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardion Health Sciences (Guardion Health Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guardion Health Sciences Inc (NAS:GHSI) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

0QTA:Germany

Address

2925 Richmond Avenue, Suite 1200, Houston, TX, USA, 77098

Website

https://www.guardionhealth.com

Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Medical Foods include Lumega-Z and GlaucoCetin; Medical Devices include Mapcat SF, VectorVision, CSV-1000 and CSV-2000; Nutraceuticals include ImmuneSF.

Executives

Katharine Joan Cox	officer: Chief Accounting Officer	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Janet Hall	officer: CEO & President	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Bradley Louis Radoff	10 percent owner	2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Family Foundation Radoff	other: See Footnote 1	2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Michaela Griggs	director	2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098
Bret Scholtes	director, officer: Chief Executive Officer	2105 CITY WEST BLVD., SUITE 500, HOUSTON TX 77042
Donald A Gagliano	director	131 CARDINAL AVE, SAN ANTONIO TX 78209
Jeffrey S Benjamin	officer: Chief Accounting Officer	3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH GA 30096
Craig Sheehan	officer: Chief Commercial Officer	15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128
Andrew C Schmidt	officer: Chief Financial Officer	1700 CARNEGIE AVE, SUITE 100, SANTA ANA CA 92705
Kelly Anderson	director	C/O TOMI ENVIRONMENTAL SOLUTIONS, INC., 9454 WILSHIRE BLVD., R-1, BEVERLY HILLS CA 90212
David W Evans	director, officer: Chief Scientific Officer	4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117
Tamara A Evans	10 percent owner	4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117
Vincent J Roth	officer: General Counsel and Secretary	15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128
Robert N Weingarten	director	5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367